Terms: = Endocrine gland cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
21 results:
1. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
[TBL] [Abstract] [Full Text] [Related]
2. Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9.
Kou X; Ding H; Li L; Chao H
Anal Cell Pathol (Amst); 2021; 2021():6662486. PubMed ID: 33680718
[TBL] [Abstract] [Full Text] [Related]
3. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
Li J; Ke J; Fang J; Chen JP
J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
[TBL] [Abstract] [Full Text] [Related]
4. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
[TBL] [Abstract] [Full Text] [Related]
5. Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts.
Topp MD; Hartley L; Cook M; Heong V; Boehm E; McShane L; Pyman J; McNally O; Ananda S; Harrell M; Etemadmoghadam D; Galletta L; Alsop K; Mitchell G; Fox SB; Kerr JB; Hutt KJ; Kaufmann SH; Australian Ovarian Cancer Study ; Swisher EM; Bowtell DD; Wakefield MJ; Scott CL
Mol Oncol; 2014 May; 8(3):656-68. PubMed ID: 24560445
[TBL] [Abstract] [Full Text] [Related]
6. Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae.
Aravindan S; Delma CR; Thirugnanasambandan SS; Herman TS; Aravindan N
PLoS One; 2013; 8(4):e61977. PubMed ID: 23613993
[TBL] [Abstract] [Full Text] [Related]
7. BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival.
Marchion DC; Cottrill HM; Xiong Y; Chen N; Bicaku E; Fulp WJ; Bansal N; Chon HS; Stickles XB; Kamath SG; Hakam A; Li L; Su D; Moreno C; Judson PL; Berchuck A; Wenham RM; Apte SM; Gonzalez-Bosquet J; Bloom GC; Eschrich SA; Sebti S; Chen DT; Lancaster JM
Clin Cancer Res; 2011 Oct; 17(19):6356-66. PubMed ID: 21849418
[TBL] [Abstract] [Full Text] [Related]
8. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells.
Arora S; Bhardwaj A; Srivastava SK; Singh S; McClellan S; Wang B; Singh AP
PLoS One; 2011; 6(6):e21573. PubMed ID: 21720559
[TBL] [Abstract] [Full Text] [Related]
9. Fertility-sparing surgery in young women with mucinous adenocarcinoma of the ovary.
Kajiyama H; Shibata K; Mizuno M; Nawa A; Mizuno K; Matsuzawa K; Kawai M; Hosono S; Nagasaka T; Kikkawa F
Gynecol Oncol; 2011 Aug; 122(2):334-8. PubMed ID: 21575985
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M; Melichar B; Sedláková I; Steiner I
Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
[TBL] [Abstract] [Full Text] [Related]
12. Primary follicular lymphoma of the testis and epididymis in adults.
Bacon CM; Ye H; Diss TC; McNamara C; Kueck B; Hasserjian RP; Rohatiner AZ; Ferry J; Du MQ; Dogan A
Am J Surg Pathol; 2007 Jul; 31(7):1050-8. PubMed ID: 17592272
[TBL] [Abstract] [Full Text] [Related]
13. HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival.
Raspollini MR; Amunni G; Villanucci A; Castiglione F; Rossi Degl'Innocenti D; Baroni G; Paglierani M; Taddei GL
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):181-6. PubMed ID: 16785787
[TBL] [Abstract] [Full Text] [Related]
14. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract] [Full Text] [Related]
15. [bcl-2 in ovarian carcinoma: a clinicopathologic, immunohistochemical and molecular study].
Raspollini MR; Castiglione F; Rossi Degl'Innocenti D; Baroni G; Amunni G; Villanucci A; Taddei GL
Pathologica; 2004 Dec; 96(6):465-9. PubMed ID: 15792372
[TBL] [Abstract] [Full Text] [Related]
16. Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease.
Williams J; Lucas PC; Griffith KA; Choi M; Fogoros S; Hu YY; Liu JR
Gynecol Oncol; 2005 Feb; 96(2):287-95. PubMed ID: 15661210
[TBL] [Abstract] [Full Text] [Related]
17. Microinvasive squamous cell carcinoma of the cervix: immunohistochemically detected prognostic factors in a case with poor clinical outcome.
Kohlberger P; Edwards L; Hacker NF
Gynecol Oncol; 2003 Aug; 90(2):443-5. PubMed ID: 12893215
[TBL] [Abstract] [Full Text] [Related]
18. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and bcl-2.
Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
[TBL] [Abstract] [Full Text] [Related]
19. Expression of bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: effects on clinical outcome and efficacy of adjuvant chemotherapy.
Nio Y; Dong M; Iguchi C; Yamasawa K; Toga T; Itakura M; Tamura K
J Surg Oncol; 2001 Mar; 76(3):188-96. PubMed ID: 11276023
[TBL] [Abstract] [Full Text] [Related]
20. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer.
Marx D; Binder C; Meden H; Lenthe T; Ziemek T; Hiddemann T; Kuhn W; Schauer A
Anticancer Res; 1997; 17(3C):2233-40. PubMed ID: 9216694
[TBL] [Abstract] [Full Text] [Related]
[Next]